Here, using the human lung adenocarcinoma A549 and immortalized bronchial epithelial BEAS-2B cellular models, we present data in support of TLE1 as an effector of anoikis resistance, which is a determinant of malignant transformation and tumor progression. The gene discussed is TLE1; the disease is lung adenocarcinoma.